Home Overview Press Room Blog Publications For Students about us
Search

About Egg Retrieval


Scientists working to perform research cloning require large numbers of women's eggs for their efforts. Egg retrieval is invasive, time-consuming, uncomfortable, and—most important—puts women at risk of significant adverse reactions.

In order to procure eggs, researchers give women hormonal drugs to first "shut down" and then "hyperstimulate" their ovaries to produce more eggs than normal. These eggs are then surgically extracted.

Egg retrieval for assisted reproduction has been conducted for several decades, but there is inadequate data on its risks. Follow-up studies on long-term risks are particularly lacking; those that do exist are inconclusive.

Short-term reactions to one commonly used "shut-down" drug include severe joint pain, difficulty breathing, chest pain, depression, amnesia, hypertension, and asthma. The drugs used to stimulate multiple egg production can cause ovarian hyperstimulation syndrome (OHSS), which is often a mild reaction but which can become serious enough to require hospitalization and, rarely, to cause death.

Some women's health advocates and others have questioned whether researchers should ask women to expose themselves to these risks, especially in light of the early and speculative stage of cloning research. Proposals to pay women to provide eggs for research remain controversial, as this practice could tempt economically vulnerable women to take risks they otherwise would avoid.



Egg Donor Loses Case Against IRS, Must Pay Taxes on Earningsby Richard RubinBloombergJanuary 22nd, 2015The U.S. Tax Court rejected a California woman’s attempt to avoid taxes on the $20,000 she received when she donated her eggs for use by infertile couples.
Key Questions About the Social and Ethical Implications of Nuclear Genome Transfer or “3-Person IVF” Techniquesby Jessica CussinsBiopolitical TimesJanuary 22nd, 2015As the Institute of Medicine launches an official assessment over the next year, here are eight questions to consider.
Institute of Medicine to Study the Social Policy and Ethics of “3-Person IVF”by Jessica CussinsBiopolitical TimesJanuary 22nd, 2015The FDA held a public meeting last year to assess the safety and efficacy of nuclear genome transfer for the prevention of transmission of mitochondrial diseases. Now it has asked the Institute of Medicine to consider the social and ethical issues.
UK May Be Poised for “Historic Mistake” on “3-Person IVF”by Jessica CussinsBiopolitical TimesJanuary 22nd, 2015A Parliamentary vote is expected as soon as February.
Three-Parent Baby Pioneer Jamie Grifo: ‘The Brits Will be Ahead of the World’by Steve ConnorThe IndependentJanuary 16th, 2015A fertility doctor insists his "three-parent embryo" technique is safe, even though the woman who became pregnant with twins using it lost both babies.
When Does the Pursuit of Pregnancy Go Too Far?by Pamela M. TsigdinosMediumJanuary 15th, 2015The unregulated and fast-growing fertility industry is predicated on a tantalizing promise: "We can get you pregnant." But at what cost?
IVF Booster Offered in Canada But Not US[Quotes CGS's Marcy Darnovsky]by Alison MotlukCanadian Medical Association JournalJanuary 14th, 2015A fertility treatment that purports to help older women get pregnant by using mitochondria from their own ovarian stem cells is now being offered in Toronto, but nowhere else in North America.
The Future of Conceptionby Jessica CussinsBiopolitical TimesJanuary 8th, 2015Numerous writers took advantage of the ending year to look broadly at just how drastically we are changing the process of baby-making, and what it all means for society.
CIRM 2.0by Pete ShanksBiopolitical TimesJanuary 7th, 2015The California Institute for Regenerative Medicine is attempting a "reboot" in an effort to accelerate the development of cures, though its critics remain skeptical.
Biopolitical News of 2014by Pete Shanks, Jessica Cussins & Marcy DarnovskyBiopolitical TimesDecember 19th, 2014This is everything important that happened in biopolitics in 2014 (or close to it).
Displaying 1-10 of 672  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760